ViroPharma Incorporated Reports Second Quarter 2009 Financial Results
...) non-cash interest expense, (2) amortization related to the acquisition of lev Pharmaceuticals and Vancocin, and step up in inventory related to purchase accounting arising from the acquisition of lev Pharmaceuticals, (3) stock compensation expenses, and (4) certain non-recur...ViroPharma Incorporated Reports Third Quarter 2008 Financial Results
...forts; Business Development: -- Acquisition of lev Pharmaceuticals completed for $442.9 million of upfront consideration, or $2.75 per lev share, comprised of $2.25 per share in cash an...k; -- Contingent consideration of up to $1.00 per lev share, or $174.6 million may be paid on achiev...OneCommunity's Scot Rourke Named Intelligent Community Visionary of the Year for 2008
...first the city of Cleveland and then the entire Northeast Ohio region. The effort began in 2002 when Cleveland's Case Western Reserve University named lev Gonick as its new CIO. Believing that the region's nonprofits should play a more active role in its recovery from industrial decline, Gonick assembled...